Clinical impact of early graft function in kidney transplant recipients on long-term dialysis: A retrospective cohort study

Table 1 Pre-transplant clinical characteristics, median (25^th-75^th percentiles)

Variables	Group LTD (n = 28)	Group STD (n = 227)	P value1
Age at Tx (years)	51 (45-55)	46 (36-57)	0.123
Male gender (%)	57.1	60.8	0.838
BMI at Tx (kg/m2)	20.52 (18.87- 21.91)	21.85 (19.41- 24.83)	0.086
Dialysis duration (years)	20.2 (17.2-24.3)	1.4 (0.5-4.9)	< 0.001
Comorbidity at Tx
Hypertension (%)	59.3	82.8	0.008
Diabetes mellitus (%)	0	19.8	0.006
Dyslipidemia (%)	17.2	7.4	0.271
History of CVD event (%)	24.0	14.2	0.236
Cause of ESKD
CGN (%)	75.0	21.6	< 0.001
ADPKD (%)	3.6	8.4	0.707
IgA nephropathy (%)	3.6	13.7	0.221
Diabetic kidney disease (%)	0	19.4	0.006
Other or unknown (%)	17.9	33.9	0.132
Deceased donor kidney Tx (%)	85.7	2.2	< 0.001
Donor age at Tx (years)	57 (44-62)	58 (51-65)	0.119
Donor male gender (%)	60.7	37.0	0.023
ABO-incompatible (%)	3.6	26.0	0.008
HLA mismatch number	3 (2-3)	3 (3-5)	0.007

¹P values were calculated using the Mann-Whitney U test for continuous variables and the χ² test for categorical variables.

Tx: Transplantation; BMI: Body mass index; CVD: Cardiovascular disease; ESKD: End-stage kidney disease; CGN: Chronic glomerulonephritis; ADPKD: Autosomal dominant polycystic kidney disease; HLA: Human leukocyte antigen; LTD: Long-term dialysis; STD: Short-term dialysis.